Keros Therapeutics, Inc. Other Nonoperating Income (Expense)
Keros Therapeutics, Inc. (KROS) reported Other Nonoperating Income (Expense) of -$60.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-03
- Keros Therapeutics, Inc. other nonoperating income (expense) for the quarter ending 2026-06-30 was -$60.00K.
- Keros Therapeutics, Inc. other nonoperating income (expense) for the quarter ending 2026-03-31 was -$166.00K.
- Keros Therapeutics, Inc. other nonoperating income (expense) for the quarter ending 2025-12-31 was $273.00K.
- Keros Therapeutics, Inc. other nonoperating income (expense) for the quarter ending 2025-09-30 was -$253.00K.
- Keros Therapeutics, Inc. other nonoperating income (expense) for fiscal 2025 was -$539.00K.
- Keros Therapeutics, Inc. other nonoperating income (expense) for fiscal 2024 was -$954.00K.
- Keros Therapeutics, Inc. other nonoperating income (expense) for fiscal 2023 was -$206.00K.
- Keros Therapeutics, Inc. other nonoperating income (expense) for fiscal 2022 was -$613.00K.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 3 month as first filed | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 6 month as first filed | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 9 month as first filed | Other Nonoperating Income (Expense) 12 month | Other Nonoperating Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$60.00K 10-Q · filed 2026-08-03 | -$226.00K 10-Q · filed 2026-08-03 | $47.00K derived: sum of 3 quarters · filed 2026-08-03 | -$206.00K derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2026-03-31 | -$166.00K 10-Q · filed 2026-05-14 | $107.00K derived: sum of 2 quarters · filed 2026-05-14 | -$146.00K derived: sum of 3 quarters · filed 2026-05-14 | -$367.00K derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-12-31 | $273.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $20.00K derived: sum of 2 quarters · filed 2026-03-04 | -$201.00K derived: sum of 3 quarters · filed 2026-08-03 | -$539.00K 10-K · filed 2026-03-04 | ||||
| 2025-09-30 | -$253.00K 10-Q · filed 2025-11-05 | -$474.00K derived: sum of 2 quarters · filed 2026-08-03 | -$812.00K 10-Q · filed 2025-11-05 | -$1.04M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-06-30 | -$221.00K 10-Q · filed 2026-08-03 | -$559.00K 10-Q · filed 2026-08-03 | -$788.00K derived: sum of 3 quarters · filed 2026-08-03 | -$880.00K derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-03-31 | -$338.00K 10-Q · filed 2026-05-14 | -$567.00K derived: sum of 2 quarters · filed 2026-05-14 | -$659.00K derived: sum of 3 quarters · filed 2026-05-14 | -$855.00K derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | -$229.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$321.00K derived: sum of 2 quarters · filed 2026-03-04 | -$517.00K derived: sum of 3 quarters · filed 2026-03-04 | -$954.00K 10-K · filed 2026-03-04 | ||||
| 2024-09-30 | -$92.00K 10-Q · filed 2025-11-05 | -$288.00K derived: sum of 2 quarters · filed 2025-11-05 | -$725.00K 10-Q · filed 2025-11-05 | -$669.00K derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-30 | -$196.00K 10-Q · filed 2025-08-06 | -$633.00K 10-Q · filed 2025-08-06 | -$577.00K derived: sum of 3 quarters · filed 2025-08-06 | -$644.00K derived: sum of 4 quarters · filed 2025-08-06 | ||||
| 2024-03-31 | -$437.00K 10-Q · filed 2025-05-06 | -$381.00K derived: sum of 2 quarters · filed 2025-05-06 | -$448.00K derived: sum of 3 quarters · filed 2025-05-06 | -$603.00K derived: sum of 4 quarters · filed 2025-05-06 | ||||
| 2023-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$11.00K derived: sum of 2 quarters · filed 2025-02-26 | -$166.00K derived: sum of 3 quarters · filed 2025-02-26 | -$206.00K 10-K · filed 2025-02-26 | ||||
| 2023-09-30 | -$67.00K 10-Q · filed 2024-11-06 | $3.84M 10-Q · filed 2023-11-06 | -$222.00K derived: sum of 2 quarters · filed 2024-11-06 | -$262.00K 10-Q · filed 2024-11-06 | $10.74M 10-Q · filed 2023-11-06 | -$1.66M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2023-06-30 | -$155.00K 10-Q · filed 2024-08-07 | $3.83M 10-Q · filed 2023-08-07 | -$196.00K 10-Q · filed 2024-08-07 | $6.90M 10-Q · filed 2023-08-07 | -$1.60M derived: sum of 3 quarters · filed 2025-02-26 | -$835.00K derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2023-03-31 | -$40.00K 10-Q · filed 2024-05-08 | $3.06M 10-Q · filed 2023-05-04 | -$1.44M derived: sum of 2 quarters · filed 2025-02-26 | -$680.00K derived: sum of 3 quarters · filed 2025-02-26 | -$594.00K derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2022-12-31 | -$1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$640.00K derived: sum of 2 quarters · filed 2025-02-26 | -$554.00K derived: sum of 3 quarters · filed 2025-02-26 | -$613.00K 10-K · filed 2025-02-26 | $3.03M 10-K · filed 2023-03-03 | |||
| 2022-09-30 | $762.00K 10-Q · filed 2023-11-06 | $848.00K derived: sum of 2 quarters · filed 2023-11-06 | $789.00K 10-Q · filed 2023-11-06 | $688.00K derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-06-30 | $86.00K 10-Q · filed 2023-08-07 | $27.00K 10-Q · filed 2023-08-07 | -$74.00K derived: sum of 3 quarters · filed 2024-02-28 | -$211.00K derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-03-31 | -$59.00K 10-Q · filed 2023-05-04 | -$160.00K derived: sum of 2 quarters · filed 2024-02-28 | -$297.00K derived: sum of 3 quarters · filed 2024-02-28 | -$377.00K derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2021-12-31 | -$101.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$238.00K derived: sum of 2 quarters · filed 2024-02-28 | -$318.00K derived: sum of 3 quarters · filed 2024-02-28 | -$383.00K 10-K · filed 2024-02-28 | -$356.00K 10-K · filed 2022-03-09 | |||
| 2021-09-30 | -$137.00K 10-Q · filed 2022-11-03 | -$217.00K derived: sum of 2 quarters · filed 2022-11-03 | -$282.00K 10-Q · filed 2022-11-03 | -$126.00K derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | -$80.00K 10-Q · filed 2022-08-04 | -$145.00K 10-Q · filed 2022-08-04 | $11.00K derived: sum of 3 quarters · filed 2022-08-04 | -$75.00K derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | -$65.00K 10-Q · filed 2022-05-05 | $91.00K derived: sum of 2 quarters · filed 2022-05-05 | $5.00K derived: sum of 3 quarters · filed 2022-05-05 | $163.00K derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | $156.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $70.00K derived: sum of 2 quarters · filed 2022-03-09 | $228.00K derived: sum of 3 quarters · filed 2022-03-09 | $160.00K 10-K · filed 2022-03-09 | ||||
| 2020-09-30 | -$86.00K 10-Q · filed 2021-11-04 | $72.00K derived: sum of 2 quarters · filed 2021-11-04 | $4.00K 10-Q · filed 2021-11-04 | $60.00K derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $158.00K 10-Q · filed 2021-08-05 | $90.00K 10-Q · filed 2021-08-05 | $146.00K derived: sum of 3 quarters · filed 2021-08-05 | $161.00K derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | -$68.00K 10-Q · filed 2021-05-06 | -$12.00K derived: sum of 2 quarters · filed 2021-05-06 | $3.00K derived: sum of 3 quarters · filed 2021-05-06 | $72.00K derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $71.00K derived: sum of 2 quarters · filed 2021-03-25 | $140.00K derived: sum of 3 quarters · filed 2021-03-25 | $241.00K 10-K · filed 2021-03-25 | ||||
| 2019-09-30 | $15.00K 10-Q · filed 2020-11-10 | $84.00K derived: sum of 2 quarters · filed 2020-11-10 | $185.00K 10-Q · filed 2020-11-10 | |||||
| 2019-06-30 | $69.00K 10-Q · filed 2020-08-13 | $170.00K 10-Q · filed 2020-08-13 | ||||||
| 2019-03-31 | $101.00K 10-Q · filed 2020-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |